Skip to main content
. 2009 Jun 25;180(6):499–505. doi: 10.1164/rccm.200903-0488OC

TABLE 1.

PATIENT CHARACTERISTICS

PCV7 (n = 57) PPSV23 (n = 63) P Value
Age, years 63 ± 10 63 ± 10 0.95
Male, % 38 (67) 37 (59) 0.45
White, % 43 (75) 48 (76) 1.0
FEV1, L 1.40 ± 0.58 1.23 ± 0.54 0.12
FEV1, % predicted 45 ± 16 43 ± 15 0.56
FEV1/FVC 0.47± 0.13 0.44 ± 0.13 0.16
Oxygen use, % 12 (21) 21 (33) 0.15
Inhaled corticosteroid use, % 36 (63) 43 (68) 0.57
Pack-years smoking 54 ± 32 55 ± 34 0.82
Comorbid illness, %
 Coronary artery disease 16 (28) 15 (24) 0.68
 Congestive heart failure 3 (5) 2 (3) 0.67
 Stroke 2 (4) 6 (9) 0.28
 Diabetes mellitus 5 (9) 3 (5) 0.48
 Prior malignancy 7 (12) 8 (13) 1.00
 Anemia 7 (12) 4 (6) 0.35
Previous pneumonia, % 26 (46) 30 (48) 0.86
Exacerbation history (yr before enrollment)
 Hospitalized or unscheduled emergency visit, % 10 (18) 9 (14) 0.80
 Received systemic steroids and/or antibiotics, % 26 (46) 26 (41) 0.71
Vaccine naive, % 30 (53) 33 (52) 1.00
Years since last vaccination 7.9 8.4 0.56

Definition of abbreviations: PCV7 = 7-valent diphtheria-conjugated pneumococcal polysaccharide vaccine; PPSV23 = 23-valent pneumococcal polysaccharide vaccine.